ANGELINE CHAU: Open Payments
NPI 1659847309 · SPRINGFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 11 payments from 6 companies in 2025. Trend: 2023 $39 · 2024 $108 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $109 |
| Optinose US, Inc. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: DUPIXENT, Xhance, XOLAIR, NEFFY, NUCALA.
Industry payments across VA — which companies pay providers there.
